GGrantIndex
← Leaderboards

Svati H. Shah

Duke University

$11,708,678
Attributed
$17,100,983
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,100,983 · 10

By mechanism

R01$12,541,063 · 5
P01$2,310,026 · 1
R56$1,350,764 · 2
R21$899,130 · 2

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Cohort

Research focus

CohortPhenotypeRisk FactorsPathway InteractionsCardiovascular DiseasesBiological MarkersMolecularMetabolomicsEventGenesTechnologyValidationHeterogeneityBiologicalBaseCardiovascular SystemMediatingMetabolicResponseGeneticFunctional DisorderBiobankFutureHigh Risk

Grant awards (28)

Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders$705,314
R01 · FY2025 · HL · contact PI
Cardiac function and proteomic biomarkers in individuals with perinatal HIV infection or exposure$571,021
R01 · FY2025 · HL
Cardiac function and proteomic biomarkers in individuals with perinatal HIV infection or exposure$227,677
R01 · FY2025 · HL
Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders$756,895
R01 · FY2024 · HL · contact PI
Immunogenetic Profiling for Risk of Primary Graft Dysfunction after Heart Transplantation$241,500
R21 · FY2023 · AI · contact PI
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$610,178
R01 · FY2022 · HL · contact PI
Immunogenetic Profiling for Risk of Primary Graft Dysfunction after Heart Transplantation$201,250
R21 · FY2022 · AI · contact PI
Inflammatory and Metabolic Biomarkers in Cardiovascular Complications with SARS-CoV-2$200,440
R21 · FY2022 · AI · contact PI
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$1,279,576
R01 · FY2021 · HL · contact PI
Proteomic Profiles and Cardiac Dysfunction in Children and Adolescents with HIV$692,531
R56 · FY2021 · HL
Inflammatory and Metabolic Biomarkers in Cardiovascular Complications with SARS-CoV-2$255,940
R21 · FY2021 · AI · contact PI
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$1,438,818
R01 · FY2020 · HL · contact PI
Project 3 - Shah$393,185
P01 · FY2020 · HL · contact PI
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$1,485,906
R01 · FY2019 · HL · contact PI
Project 3 - Shah$494,309
P01 · FY2019 · HL · contact PI
A Personalized Metabolomic Approach to Human Obesity and Weight Loss$321,972
R01 · FY2019 · HL · contact PI
A Personalized Metabolomic Approach to Human Obesity and Weight Loss$516,591
R01 · FY2018 · HL · contact PI
Project 3 - Shah$495,581
P01 · FY2018 · HL · contact PI
A Personalized Metabolomic Approach to Human Obesity and Weight Loss$596,091
R01 · FY2017 · HL · contact PI
Project 3 - Shah$485,405
P01 · FY2017 · HL · contact PI
A Personalized Metabolomic Approach to Human Obesity and Weight Loss$622,766
R01 · FY2016 · HL · contact PI
Project 3 - Shah$441,546
P01 · FY2016 · HL · contact PI
Systems Biology Approaches for Predicting Cardiometabolic Risk in Persons Living with HIV$658,233
R56 · FY2015 · HL · contact PI
Metabolomic Quantitative Trait Locus (mQTL) Genetic Mapping in Human CVD$552,549
R01 · FY2013 · HL · contact PI
Metabolomic Quantitative Trait Locus (mQTL) Genetic Mapping in Human CVD$567,973
R01 · FY2012 · HL · contact PI
Metabolomic Quantitative Trait Locus (mQTL) Genetic Mapping in Human CVD$774,451
R01 · FY2011 · HL · contact PI
Metabolomic Quantitative Trait Locus (mQTL) Genetic Mapping in Human CVD$765,242
R01 · FY2010 · HL · contact PI
Metabolomic Quantitative Trait Locus (mQTL) Genetic Mapping in Human CVD$748,043
R01 · FY2009 · HL · contact PI